ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.425
-0.026 (-1.79%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.026 -1.79% 1.425 1.402 1.448 1.42 1.41 1.42 3,614,132 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0059 -2.39 16.1M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.45p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £16.10 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.39.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 376 to 398 of 13425 messages
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
01/3/2018
09:37
Align - Not as bad as some..always DYor
tsmith2
01/3/2018
09:36
10p easily here!!!
cudmore
01/3/2018
09:29
I hate align with a passion but for once I'm benefiting from their ramp in this one today. Hard to sell and buy back cheaper mm's shut down limits quick to sell and buy when it suits them. Trend for now is higher highs
dave4545
01/3/2018
09:25
Second leg of 5 gearing up.
tidy 2
01/3/2018
09:23
I have to say I felt the RNS released was fantastic news and clearly the co got a bit over excited when someone tweeted when they shouldn't have.Need to remember this is not an AIM co either.In addition I liked the pro active interview and IMO a partner will see this rocket.I can wait for that day.Have to say PYC also will do the same once a second sizeable partner is announced and I believe they are way undervalued also. Could this be the year of the pharmas?
billthebank
01/3/2018
09:21
Align's note will now be being received by folks who are on their emailing list.

At the start of today it would have been only those who had been checking today's RNS's.

f

fillipe
01/3/2018
09:18
It should go up. Align, often put these out when they have taken a position and the shares go down.
ayesha4
01/3/2018
09:15
Shorts closing. Next leg up coming?
orchestralis
01/3/2018
09:13
Tidy 2 going for gold
jimmyhoffa262
01/3/2018
09:13
Align are pumpers and dumpers led by Richie Rich.
ayesha4
01/3/2018
09:06
The Company is pleased to note the comments of Align in their research note ("Note") including its "conviction buy" stance and target price of 18.15 pence.Nice little RNS there.
tidy 2
01/3/2018
08:56
data results have shown that CDX bi-specific antibodies are capable of attacking and eliminating the blood cancer Acute Myelogenous Leukemia (AML)
tidy 2
01/3/2018
08:47
They are also now in the process of proving to several major pharma's that the cancer cure is a success in addition to proving that they also have humanised mice that can be used for numerous other drug testing. Sounds impressive.
tidy 2
01/3/2018
08:42
So the break through has the addition of humanised mice which can be used for purposes beyond proving their cancer cure works.
tidy 2
01/3/2018
08:40
Unlike at VAL no YA to deal with, warrants will bring in enough fully funded to 2019.Deals with large pharmas on horizon ..
tsmith2
01/3/2018
08:37
Broker has a target of 18p. That's without the news of the several major pharma's they're now working with.
tidy 2
01/3/2018
08:32
Shake over now you cannot buy online again
dave4545
01/3/2018
08:28
Already in talks and working close with SEVERAL major pharma's
tidy 2
01/3/2018
08:28
"data results have shown that CDX bi-specific antibodies are capable of attacking and eliminating the blood cancer Acute Myelogenous Leukemia (AML) in vitro. Using these new humanised mice the Company is confident that it should be able to demonstrate that its lead product, CDX bi-specific antibodies, are effective in the treatment of (AML). Use of the humanised mouse model should facilitate developing and progressing the CDX bi-specific antibodies into human trials, in line with the Company's development timeline."
tidy 2
01/3/2018
08:21
mm's are going to shake it big style. They will only let people sell online at a price that suits them and their profits.
dave4545
01/3/2018
08:15
im just saying it makes the company lookbad.tacky.

some people are in for the long game
ie 2-3 years and don't care about day to day little movements....

moneytree1
01/3/2018
08:12
*stonking!!
tsmith2
01/3/2018
08:12
ps - I think VAL are a stinking buy too
tsmith2
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older